Salmeterol/fluticasone propionate

DRUG4 trials

Sponsors

GlaxoSmithKline, Fudan University, Almirall, S.A.

Conditions

AsthmaChronic Obstructive Pulmonary Disease (COPD)Pulmonary Disease, Chronic Obstructive

Phase 1

A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhaled Long-acting Beta-agonist and Corticosteroid

CompletedNCT02094274

Almirall, S.A.Asthma

Start: 2013-11-30End: 2014-05-31Updated: 2014-05-22

Phase 4

Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.

CompletedNCT00169546

GlaxoSmithKlineAsthma

Start: 2003-01-31End: 2005-12-31Updated: 2016-09-15

The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD

Fudan UniversityChronic Obstructive Pulmonary Disease (COPD)

Start: 2009-07-31End: 2011-10-31Target: 450Updated: 2010-11-19

Unknown Phase

Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT00662805

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2004-06-30End: 2008-09-30Updated: 2014-01-20